Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
Hamed Dabiri, Pooria Safarzadeh Kozani, Mahdi Habibi‐Anbouhi, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 3
The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution
Artyom Kachanov, Anastasiya Kostyusheva, Sergey Brezgin, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2112-2193
Closed Access | Times Cited: 12
Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives
Lucija Levstek, Larisa Janžič, Alojz Ihan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods
Yekta Metanat, Patrik Viktor, Ayesha Amajd, et al.
Life Sciences (2024) Vol. 348, pp. 122683-122683
Closed Access | Times Cited: 11
Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review
Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies
Kexin Ai, Bowen Liu, Xiaomei Chen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Universal CAR 2.0 to overcome current limitations in CAR therapy
Lara Sophie Schlegel, Coralie Werbrouck, Michael Boettcher, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Construction and characterization of chimeric FcγR T cells for universal T cell therapy
Juanjuan Zhao, Manling Chen, Xudong Li, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Mechanisms of antigen-dependent resistance to chimeric antigen receptor (CAR)-T cell therapies
Fatemeh Nasiri, Pouya Safarzadeh Kozani, Faeze Salem, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration: a comprehensive review
Gils Roex, Khloe S. Gordon, Eva Lion, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e010658-e010658
Open Access
Optimizing viral transduction in immune cell therapy manufacturing: key process design considerations
Liu Dan, Lee Kang-Zheng
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer
Fatemeh Nasiri, Khadijeh Farrokhi, Pouya Safarzadeh Kozani, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Precision Targeting and Genetically Modified T Cells for Targeting Cancer Cells
Dr Ammar A. Razzak Mahmood, Sudhakar Srinivasan, Challaraj Emmanuel E. S
International Journal of Trends in OncoScience (2024), pp. 1-9
Open Access | Times Cited: 2
In vivo gene editing and in situ generation of chimeric antigen receptor cells for next-generation cancer immunotherapy
Weiyue Zhang, Xin Huang
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Targeted Delivery of Chimeric Antigen Receptor into T Cells via CRISPR-Mediated Homology-Directed Repair with a Dual-AAV6 Transduction System
Pablo Diego Moço, Omar Farnós, David Sharon, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 7705-7720
Open Access | Times Cited: 5
DMPK perspective on quantitative model analysis for chimeric antigen receptor cell therapy: Advances and challenges
Akihiko Goto, Yuu Moriya, Miyu Nakayama, et al.
Drug Metabolism and Pharmacokinetics (2024) Vol. 56, pp. 101003-101003
Open Access | Times Cited: 1
Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR–T) cell immunotherapy
Zhengyi Wang, LIANG ZHOU, XIAOYING WU
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 9, pp. 1479-1516
Open Access | Times Cited: 1
BRD4 inhibitor reduces exhaustion and blocks terminal differentiation in CAR-T cells by modulating BATF and EGR1
Songnan Sui, Mengjun Zhong, Shuxin Zhong, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Regulation of CAR transgene expression to design semiautonomous CAR-T.
Paweł Głowacki, Cezary Tręda, Piotr Rieske
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200833-200833
Open Access
Antifragile Treatment for Efficient Chimerism of Induced Pluripotent Stem Cells Derived Hematopoietic Stem Cells
Daekee Kwon, T.R. Lee, Mijung Han, et al.
Stem Cell Reviews and Reports (2024)
Open Access
Page 1

Scroll to top